Participants Recruited for Study on Premenstrual Dysphoric Disorder

by Medindia Content Team on November 14, 2007 at 4:01 PM
Participants Recruited for Study on Premenstrual Dysphoric Disorder

Yale School of Medicine is recruiting participants for a study into a new treatment method for premenstrual dysphoric disorder (PMDD), which is a severe and debilitating form of premenstrual syndrome (PMS). PMDD is believed to affect between three percent and eight percent of women.

Women under medical treatment for PMDD currently take anti-depressants every day, or for half of the menstrual cycle (14-16 days). The goal of the study is to see if the patients feel better by taking the medication only on the days that they are experiencing symptoms. For the majority of PMDD sufferers, that is about six days. The advantages of this are fewer possible side effects from the medication and a lower cost.


The principal investigator, Kimberly Yonkers, M.D., associate professor of psychiatry and obstetrics, gynecology, and reproductive sciences, said subjects will take the anti-depressant sertraline for six months at the onset of symptoms, or will receive a placebo.

The goal is to enroll 300 women between the three sites—Cornell University, Virginia Commonwealth University, and Yale University. Yonkers said patients with PMDD experience at least one mood symptom, such as depression, mood swings, irritability, anxiety, and feelings that life is not worth living.

She said 15 percent of women with PMDD attempt suicide. These symptoms, which occur only premenstrually, are often accompanied by changes in sleep and appetite, changes in energy, breast pain, and bloating—all of which can be severe and lead to disturbances in functioning at home or at work.

"While it is common to trivialize premenstrual disturbances such as PMDD, the illness is serious for the women who are afflicted," Yonkers said.

For more information, please contact the project's director, Joanne Cunningham, or

Source: YALE University
Font : A-A+



Latest Women Health News

AI Tool Precisely Detects Postpartum Hemorrhage
An AI tool called Flan-T5 identified postpartum hemorrhage with 95% precision and detected 47% patients with the condition.
Active Scrutiny of Cervical Lesions Fuels Long-Term Cervical Cancer Risk
Active surveillance of cervical lesions was associated with higher cervical cancer risk in the long term compared to its removal.
Contraceptive Pills To Go Over-the-Counter Sale in Japan
Japan initiated the trial of selling morning-after contraceptive tablets over-the-counter in an effort to lower abortion rates and solace for rape victims.
Urinary Tract Infections Surge in Indian Women Due to Ignorance
The rising number of urinary tract infections (UTIs) among Indian women can be attributed primarily to social stigma and a lack of awareness.
Auto-Immune Disease of Pregnancy Linked to Fetal Heart Disorders
Pregnant women with Sjogren's or lupus syndrome have elevated anti-Ro/SSA antibodies which are linked to fetal atrioventricular block in the heart.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Participants Recruited for Study on Premenstrual Dysphoric Disorder Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests